90 related articles for article (PubMed ID: 17517502)
1. Ginkgo biloba in dyslexia: a pilot study.
Donfrancesco R; Ferrante L
Phytomedicine; 2007 Jun; 14(6):367-70. PubMed ID: 17517502
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled, randomized trial of Ginkgo biloba extract EGb 761 in a sample of cognitively intact older adults: neuropsychological findings.
Mix JA; Crews WD
Hum Psychopharmacol; 2002 Aug; 17(6):267-77. PubMed ID: 12404671
[TBL] [Abstract][Full Text] [Related]
3. An examination of the efficacy of Ginkgo biloba extract EGb761 on the neuropsychologic functioning of cognitively intact older adults.
Mix JA; Crews WD
J Altern Complement Med; 2000 Jun; 6(3):219-29. PubMed ID: 10890330
[TBL] [Abstract][Full Text] [Related]
4. Ginkgo biloba extract EGb 761® in children with ADHD.
Uebel-von Sandersleben H; Rothenberger A; Albrecht B; Rothenberger LG; Klement S; Bock N
Z Kinder Jugendpsychiatr Psychother; 2014 Sep; 42(5):337-47. PubMed ID: 25163996
[TBL] [Abstract][Full Text] [Related]
5. Ginkgo biloba extract EGb 761 in dementia: intent-to-treat analyses of a 24-week, multi-center, double-blind, placebo-controlled, randomized trial.
Kanowski S; Hoerr R
Pharmacopsychiatry; 2003 Nov; 36(6):297-303. PubMed ID: 14663654
[TBL] [Abstract][Full Text] [Related]
6. Ginkgo biloba special extract EGb 761 in generalized anxiety disorder and adjustment disorder with anxious mood: a randomized, double-blind, placebo-controlled trial.
Woelk H; Arnoldt KH; Kieser M; Hoerr R
J Psychiatr Res; 2007 Sep; 41(6):472-80. PubMed ID: 16808927
[TBL] [Abstract][Full Text] [Related]
7. Ginkgo biloba and donepezil: a comparison in the treatment of Alzheimer's dementia in a randomized placebo-controlled double-blind study.
Mazza M; Capuano A; Bria P; Mazza S
Eur J Neurol; 2006 Sep; 13(9):981-5. PubMed ID: 16930364
[TBL] [Abstract][Full Text] [Related]
8. Comparison of two dosages of ginkgo biloba extract EGb 761 in patients with peripheral arterial occlusive disease Fontaine's stage IIb. A randomised, double-blind, multicentric clinical trial.
Schweizer J; Hautmann C
Arzneimittelforschung; 1999 Nov; 49(11):900-4. PubMed ID: 10604042
[TBL] [Abstract][Full Text] [Related]
9. [Placebo-controlled double-blind study of the effectiveness of Ginkgo biloba special extract EGb 761 in trained patients with intermittent claudication].
Blume J; Kieser M; Hölscher U
Vasa; 1996; 25(3):265-74. PubMed ID: 8967154
[TBL] [Abstract][Full Text] [Related]
10. Ginkgo biloba special extract in dementia with neuropsychiatric features. A randomised, placebo-controlled, double-blind clinical trial.
Napryeyenko O; Borzenko I;
Arzneimittelforschung; 2007; 57(1):4-11. PubMed ID: 17341003
[TBL] [Abstract][Full Text] [Related]
11. Ginkgo biloba for attention-deficit/hyperactivity disorder in children and adolescents: a double blind, randomized controlled trial.
Salehi B; Imani R; Mohammadi MR; Fallah J; Mohammadi M; Ghanizadeh A; Tasviechi AA; Vossoughi A; Rezazadeh SA; Akhondzadeh S
Prog Neuropsychopharmacol Biol Psychiatry; 2010 Feb; 34(1):76-80. PubMed ID: 19815048
[TBL] [Abstract][Full Text] [Related]
12. Evidence of the regulatory effect of Ginkgo biloba extract on skin blood flow and study of its effects on urinary metabolites in healthy humans.
Boelsma E; Lamers RJ; Hendriks HF; van Nesselrooij JH; Roza L
Planta Med; 2004 Nov; 70(11):1052-7. PubMed ID: 15549661
[TBL] [Abstract][Full Text] [Related]
13. Demonstration of the efficacy of ginkgo biloba special extract EGb 761 on intermittent claudication--a placebo-controlled, double-blind multicenter trial.
Peters H; Kieser M; Hölscher U
Vasa; 1998 May; 27(2):106-10. PubMed ID: 9612115
[TBL] [Abstract][Full Text] [Related]
14. The effect of Ginkgo biloba on functional measures in multiple sclerosis: a pilot randomized controlled trial.
Johnson SK; Diamond BJ; Rausch S; Kaufman M; Shiflett SC; Graves L
Explore (NY); 2006 Jan; 2(1):19-24. PubMed ID: 16781604
[TBL] [Abstract][Full Text] [Related]
15. Effect of the herbal extract combination Panax quinquefolium and Ginkgo biloba on attention-deficit hyperactivity disorder: a pilot study.
Lyon MR; Cline JC; Totosy de Zepetnek J; Shan JJ; Pang P; Benishin C
J Psychiatry Neurosci; 2001 May; 26(3):221-8. PubMed ID: 11394191
[TBL] [Abstract][Full Text] [Related]
16. Ginkgo biloba for the treatment of vitilgo vulgaris: an open label pilot clinical trial.
Szczurko O; Shear N; Taddio A; Boon H
BMC Complement Altern Med; 2011 Mar; 11():21. PubMed ID: 21406109
[TBL] [Abstract][Full Text] [Related]
17. Ginkgo biloba for mild to moderate dementia in a community setting: a pragmatic, randomised, parallel-group, double-blind, placebo-controlled trial.
McCarney R; Fisher P; Iliffe S; van Haselen R; Griffin M; van der Meulen J; Warner J
Int J Geriatr Psychiatry; 2008 Dec; 23(12):1222-30. PubMed ID: 18537221
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled study of extract of ginkgo biloba added to clozapine in patients with treatment-resistant schizophrenia.
Doruk A; Uzun O; Ozşahin A
Int Clin Psychopharmacol; 2008 Jul; 23(4):223-7. PubMed ID: 18545061
[TBL] [Abstract][Full Text] [Related]
19. Polysomnographic effects of adjuvant ginkgo biloba therapy in patients with major depression medicated with trimipramine.
Hemmeter U; Annen B; Bischof R; Brüderlin U; Hatzinger M; Rose U; Holsboer-Trachsler E
Pharmacopsychiatry; 2001 Mar; 34(2):50-9. PubMed ID: 11302564
[TBL] [Abstract][Full Text] [Related]
20. Effect of two doses of ginkgo biloba extract (EGb 761) on the dual-coding test in elderly subjects.
Allain H; Raoul P; Lieury A; LeCoz F; Gandon JM; d'Arbigny P
Clin Ther; 1993; 15(3):549-58. PubMed ID: 8364946
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
